Special Issues
Recent progress in high-resolution mass spectrometry (HRMS) and liquid chromatography–mass spectrometry (LC–MS) methods for the structural characterization of brentuximab vedotin and trastuzumab emtansine are presented.
Sarah Cianferani
Advertisement
Articles by Sarah Cianferani
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on LCGC International
1
Fast Low-Pressure Chiral GC for Pesticides in Wine
2
Industry Roundup: Air Products Advances Gas Chromatography Performance
3
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
4
AI/ML Now: Bringing Autonomous Digital Twin Workflows Into the Laboratory
5